A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS) by Marlies Ostermann, David C. Corteville, Kent Doi, Jay L. Koyner, Andre Lamy, Gerry Li, Christine M. Solinsky, Pamela D. Winterberg, William T. Smith, Ravindra L. Mehta, Patrick T. Murray, Andrew D. Shaw, Alexander Zarbock, Daniel T. Engelman

Get full text

Drainology: Leveraging research in chest-drain management to enhance recovery after cardiothoracic surgeryCentral MessagePerspective by Kevin W. Lobdell, MD, Louis P. Perrault, MD, PhD, Rachel H. Drgastin, BS, Alessandro Brunelli, MD, Robert J. Cerfolio, MD, MBA, Daniel T. Engelman, MD, Michael C. Grant, MD, Rawn Salenger, MD, Shannon Crotwell, RN, CCRN, Busra Cangut, MD

Get full text